Kelapher 2.B

Description
Patented medical device.
Topical therapy of all trophic-dyschromic changes of dermo-epidermal tissue.
Postoperative bruises and hematomas (post-blepharoplasty, etc.), post-sclerotherapy hemosiderin discoloration, prevention of iron-dependent venous ulcers, varicose ulcers, bedsores, fissures, burns, delayed wound healing, post-laser therapy (epilation, ablative and non-ablative).

How to use
Each time the cream is applied, it is necessary to clean the affected area with saline solution. The quantity and number of applications vary depending on the clinical condition of the lesions and the absorption time of the cream. However, at least two applications per day are recommended.

components
Polyethylene glycol 400, polyethylene glycol 1,500, polyethylene glycol 4,000, lactoferrin LT (Lipid Technology), sorbitol, glycerol, allantoin, tocopherol.

warnings
Do not use if packaging is damaged. For external use only.
The simultaneous use of creams and/or similar products on the same anatomical area may compromise the effectiveness and safety of the device. Do not dispose of the product in the environment after use. Keep out of reach of children. Do not ingest. In case of accidental ingestion, consult a doctor. Do not use after the expiry date.

Conservation
Keep the packaging tightly closed, at a temperature not exceeding 25°C, in a dry place, away from light and heat sources.

Format
5 sterile single-dose applicators of 5 ml each.

Code 5010075